Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s disease

24 May 2018

Abstract excerpt

Because of their low levels of expression and the inadequacy of current research tools, CB 2 cannabinoid receptors (CB 2 R) have been difficult to study, particularly in the brain. This receptor is especially relevant in the context of neuroinflammation, so novel tools are needed to unveil its pathophysiological role(s). We have generated a transgenic mouse model in which the expression of enhanced green...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cannabis and Cannabinoid Research
Share to Pharmacological Receptor Mechanisms and Effects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29793509
DOI: 10.1186/s12974-018-1174-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s diseasePMID 29793509Read ↗

Cannabinoid receptor CB2 ablation protects against TAU induced neurodegenerationSemantic proximity Read ↗

Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer-like symptoms in a transgenic animal modelSemantic proximity Read ↗

Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.Semantic proximity Read ↗

The interplay between CB <sub>2</sub> and NMDA receptors in Parkinson’s diseaseSemantic proximity Read ↗

Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson´s diseaseSemantic proximity Read ↗

Rethinking Alzheimer’s: Harnessing Cannabidiol to Modulate IDO and cGAS Pathways for Neuroinflammation ControlSemantic proximity Read ↗

Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice.Semantic proximity Read ↗

Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis.Semantic proximity Read ↗

Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer's disease-like mice overexpressing the human mutant amyloid precursor protein.Semantic proximity Read ↗

Genetic Manipulation of the Endocannabinoid System.Semantic proximity Read ↗

Differences in the co-distribution of the Cannabinoid Receptor-1, FAAH, and MAGL in the human and mouse brain could be limiting clinical translation of endocannabinoid outcomes in mouse models of Alzheimer diseaseSemantic proximity Read ↗

Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.